What factors determine the choice of treatment in the management of intermediate (BCLC stage B) hepatocellular carcinoma?
What features would help you decide between TACE vs. TARE vs. external beam radiation therapy?
Answer from: Radiation Oncologist at Academic Institution
For Stage B disease, the major factors that I use to determine treatment (we discuss all such cases at our institutional multidisciplinary liver tumor board) are performance status, Child Pugh score/liver function, and the extent of disease. If patients have PS 0-2 and are CPA/B7, these patients may...